CoChat

Prenatal Origins of Endometriosis Pathology and Pain: Reviewing the Evidence of a Role for Low Testosterone

Open access
Crespi, Bernard J, Evans, Susan F · 2023 · Journal of Pain Research

The DOI matches its Crossref record; 93 of the 93 references it cites were found in a registry or an index; 42 of the 75 sources its claims cite were checked for support.

Abstract

Endometriosis is a polygenic, estrogen-dependent, inflammatory disorder of uncertain aetiology associated with pain, infertility and reduced quality of life. While the positive association between endometriosis and estrogen is established, a suite of recent studies has demonstrated an inverse association between the presence of endometriosis lesions and levels of testosterone both prenatally and postnatally. The following narrative review provides new insights into the roles of testosterone in the aetiology, diagnosis, and management of endometriosis and associated symptoms, especially pain. A relatively short anogenital distance (AGD) is indicative of lower levels of testosterone during fetal development. A shorter AGD has recently been correlated with both a higher risk of developing endometriosis in adult life, and with known correlates of endometriosis including earlier onset of reproductive cycling, lower ovarian follicle number, lower postnatal testosterone, and premature ovarian insufficiency. During adult life, lower levels of testosterone are positively associated with key comorbidities of endometriosis, including days per month of pelvic pain and increased pain sensitivity. Biochemically, lower levels of testosterone are associated with higher levels of pro-inflammatory IL-1β and lower levels of β-endorphin. In rodents, prenatal administration of testosterone to females reduces their pain sensitivity in adulthood. The emerging convergent links of endometriosis with low prenatal and postnatal testosterone provide evidence of a centrally mediated effect beginning in early prenatal development, and persisting through adult life, with notable effects on pain sensitivity. They generate a novel conceptual framework for understanding, studying and treating this disorder, whereby endometriosis is mediated by a combination of high estrogen in endometrial tissue with low systemic and ovarian testosterone.

Overview

CoChat Summary

TL;DR

This narrative review argues that endometriosis risk and pain may arise partly from low prenatal and postnatal testosterone, with shorter anogenital distance (AGD) as a marker of low fetal androgen exposure. It proposes a developmental framework in which endometriosis reflects high endometrial estrogen together with low systemic/ovarian testosterone.

Key findings

  • Shorter AGD, a proxy for lower prenatal testosterone, is associated with endometriosis: Mendiola et al. reported an odds ratio of 41.6 (p = 0.002) for deep infiltrating endometriosis in women with AGD below the mean, and Crestani et al. reported diagnostic specificity 0.98 and positive predictive value 0.97 for MRI-measured AGD-AF <20 mm.
  • Low postnatal testosterone is linked to pain: days per month of pelvic pain show strong inverse correlations with androgen levels, especially the free androgen index; prenatal testosterone administration to female rats reduced adult pain responses similar to males.
  • Proposed mechanisms include lower testosterone associated with higher pro-inflammatory IL-1β and lower β-endorphin, plus immunosuppressive effects of androgens; testosterone administration increased β-endorphin in brains and plasma of ovariectomized rats.
  • Genetic evidence includes an FSHB haplotype conferring higher endometriosis risk that is also associated with lower serum testosterone, lower luteinizing hormone, heavier menstruation, shorter menstrual cycles, earlier menarche, and earlier menopause.

Methods

  • Hypothesis-driven narrative review evaluating the theory that low testosterone contributes to endometriosis risk and symptoms, especially pain.
  • Literature was collected through comprehensive searches focused on prenatal and postnatal testosterone in endometriosis and its correlates; articles were included if they provided insight into the hypothesis.
  • No systematic review protocol, meta-analysis, or formal quality appraisal is described.

Limitations

  • The paper states that one recent study found no significant AGD difference, perhaps partly because sample sizes were relatively small; it also notes that the relationship between amniotic fluid testosterone and fetal AGD remains unknown.
  • The paper states that interpretation is complicated by the presence of both endometriosis and PCOS in some individuals, and that some naltrexone studies have been inconclusive.
  • Evident from the text: this is a narrative review without systematic search or quality assessment, and many causal claims rely on observational human studies and animal models rather than direct experimental tests in endometriosis.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.2147/jpr.s389166

Cites

93 of 93 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Figures

Figure 1 Depiction of measurements used for the two metrics of anogenital distance, in women.
Figure 1 Depiction of measurements used for the two metrics of anogenital distance, in women.CC BY-NC · PubMed Central
Figure 2 Lower prenatal testosterone is caused by a variety of factors, and mediates a suite of effects on the development of female physical and reproductive traits, including increased risk for endometriosis.
Figure 2 Lower prenatal testosterone is caused by a variety of factors, and mediates a suite of effects on the development of female physical and reproductive traits, including increased risk for endometriosis.CC BY-NC · PubMed Central

Verification

Claims the paper makes

31 Valid · 3 Not valid · 20 Not checked · 8 Own results and interpretations

40 more claims · 19 with their cited sources checked

Create a free account to see all 62 claims and every source verdict.

See all claims — free account
  • It may state two separate claims as one. 14
  • Probably not a substantial claim. 3

Create a free account to see these claims.

Citations

Cites

Show all 93 references

Research works printed but not linked: 5

  1. 2020, Endotext [Internet]
  2. 2000, Endotext [Internet]
  3. Smith, 2012, Pain Physician, 15, ES145
  4. Wortsman, 1984, Obstet Gynecol, 63, 630
  5. 2022, StatPearls [Internet]

Cited by

Metadata

Authors
Crespi, B. J., & Evans, S. F.
Affiliations
  • Simon Fraser University (CA)
  • The University of Adelaide (AU)
Corresponding author
Crespi, Bernard J
Venue
Journal of Pain Research
Published
2023-02
Volume
Volume 16
Pages
307-316
ISSN
1178-7090 (ISSN-L)
OpenAlex
W4318987218
Cited by
17
References
93
Citations by year
2026: 3 · 2025: 6 · 2024: 7 · 2023: 1
FWCI
4.31
Type
journal article
Language
en
Open access
Locations
  • Journal of Pain Research (publishedVersion, cc-by-nc)
  • PubMed Central (publishedVersion, cc-by-nc)
  • PubMed (publishedVersion)
  • Dove Medical Press (Taylor and Francis Group) (submittedVersion, cc-by-nc)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
Natural Sciences and Engineering Research Council of Canada
Topics
  • Health Sciences › Medicine › Reproductive Medicine › Endometriosis Research and Treatment
  • Physical Sciences › Environmental Science › Health, Toxicology and Mutagenesis › Effects and risks of endocrine disrupting chemicals
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Sexual Differentiation and Disorders
Keywords
endometriosis, prenatal testosterone, anogenital distance, endometriosis-associated pain, pelvic pain, pain sensitivity, estrogen, premature ovarian insufficiency, ovarian follicle count, IL-1β, beta-endorphin, inflammation, infertility

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

The claim verdicts this report counts are experimental: their accuracy is not yet measured.

A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Cited sources are checked with a language model’s help (gpt-6-sol).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.